Pfizer's Xejanz nearly a $1B in sales! Wait, that's better than Kyprolis! Amgen BD fail!

Quote

anonymous

Guest
http://www.pfizer.com/system/files/...roduct Revenues (Includes Historicals)_0.xlsx


  • Xejanz had $927M in sales in 2016, up from $523M in 2015. That's almost doubling of revenue. Isn't this drug supposed to have safety concerns? Isn't it in a crowded market witn multiple biologics, no access because of Enbrel and Humira? Maybe - but it's on the cusp of being a blockbuster.
  • Ibrance, the drug Amgen gets royalties from because of Onyx, for 2016 had sales of $2.1B. This drug launch in Feb 2015 and had first year sales of $700M. So in one whole year, Pfizer TRIPLED the sales of this oncology drug. What has Kyprolis done? Still lagging and waiting to be a $1B 4.5 years post launch. How fucking sad and shameful Amgen is.
 




Xeljanz had to discount like crazy to the PBMs, all for crappy coverage and they didn't make a billion in year 6.

Otezla didn't discount anywhere, all for crappy coverage and they sold over a billion in 2 years.

Why can't we realize that if you just let us go see docs instead of doing speaker programs, development plans, stakeholder meetings, LGBT awareness summits, teleconferences, web events, etc that we could sell more?

Otezla has the worst data out there, they have nothing new since launch, they have zero access and they hit a billion in 25 months? Sometimes it's best to actually call on docs.
 




Xeljanz launched in November of 2012. It's been on market only for 4 full years not 6. Hell it launched after Kyprolis and is making more money in a more crowded market.
 




anonymous said:
Xeljanz launched in November of 2012. It's been on market only for 4 full years not 6. Hell it launched after Kyprolis and is making more money in a more crowded market.
Click to expand...

Once again Amgen gets out pharma-ed by Pfizer and then out bioteched by celgene. Amgen is mediocrity with only drugs in monopoly markets that make the company appear successful
 








Mentioning LGBT awareness meeting, as one of many items preventing sales reps from calling on doctors, and not selling, seemed factual. Calling someone a homophobe seemed uncalled for - don't be a hater.
 




This is what happens when a supportive care company tries to sell a therapeutic. The unearned arrogance at Amgen, coupled with a toxic culture where all the tenured reps who knew anything about MM left due to Amgen being a toxic company and it's no surprise that Kyprolis is dieing a slow death. I've sat in those meetings with Dickey P, his lapdog MC and the rest and it is unnerving how little they understand about therapeutics and MM. Their, 'selling a drug is selling a drug' mentality is!one of many things wrong with the laughing stock of a company. All one had to do is look around the room and hear people speak in SLC to know this is a D player company with D player talent.
 




anonymous said:
This is what happens when a supportive care company tries to sell a therapeutic. The unearned arrogance at Amgen, coupled with a toxic culture where all the tenured reps who knew anything about MM left due to Amgen being a toxic company and it's no surprise that Kyprolis is dieing a slow death. I've sat in those meetings with Dickey P, his lapdog MC and the rest and it is unnerving how little they understand about therapeutics and MM. Their, 'selling a drug is selling a drug' mentality is!one of many things wrong with the laughing stock of a company. All one had to do is look around the room and hear people speak in SLC to know this is a D player company with D player talent.
Click to expand...

I came from primary care to amgen to sell this drug and you are so wrong. All drug selling is about relationships and oncologist are still doctors. Same as internal medicine and family medicine. They all go to the same medical school for 4 years buddy. You are so good that I bet you were fired from amgen. Couldn't hack it you loser.
 




anonymous said:
I came from primary care to amgen to sell this drug and you are so wrong. All drug selling is about relationships and oncologist are still doctors. Same as internal medicine and family medicine. They all go to the same medical school for 4 years buddy. You are so good that I bet you were fired from amgen. Couldn't hack it you loser.
Click to expand...

I came from primary care too and now sell Kyprolis. A good rep is a good rep and a doctor is a doctor. I don't see why you experienced oncology reps think your shit doesn't stink. I get it you have longer term relationships but that's it. Oncology is so easy but you try and make it seem like rocket science and need A phd to understand it. I was a 2.1 GPA liberal arts major at a tier 4 state school and the oncologist often think I went to med school. Honestly primary care is harder and oncology is so easy and I make more money that's it's a crime. I have no respect for any of you long term reps because I realize how dumb you guys are but act like won a Nobel science prize.
 




Oncology is an overrated and overpaid division at any company.

Oncology is all about survival data. You have or you don't. Then how many more months do you add compared to older treatments.

That's it. So fucking easy.

Those former Genentech reps who think they built the oncology world have no idea that their accomplishment is so easy and unimpressive.
 




That's why your sales have stalled after you lost all of your Onyx reps who actually understand oncology right? If not then explain why you haven't grown revenue. Kyprolis has been between 130M to 140M of the last 6 quarters.
 




anonymous said:
I came from primary care to amgen to sell this drug and you are so wrong. All drug selling is about relationships and oncologist are still doctors. Same as internal medicine and family medicine. They all go to the same medical school for 4 years buddy. You are so good that I bet you were fired from amgen. Couldn't hack it you loser.
Click to expand...

Yeah they don't go to the same fellowship dummy.
 




Top Bottom
Back
Quote